Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy

References

• Rothova A, Ooijman F, Kerkhoff F, Van der Lelij A, Lokhorst HM. Uveitis masquerade syndromes. Ophthalmology. 2001;108(2):386–399. doi:10.1016/S0161-6420(00)00499-1.
   PubMed Web of Science ®Google Scholar
• Coupland SE, Damato B. Understanding intraocular lymphomas. Clin Exp Ophthalmol. 2008;36(6):564–578. doi:10.1111/j.1442-9071.2008.01843.x.
   PubMed Web of Science ®Google Scholar
• Coupland SE, Chan CC, Smith J. Pathophysiology of retinal lymphoma. Ocul Immunol Inflamm. 2009;17(4):227–237. doi:10.1080/09273940903168696.
   PubMed Web of Science ®Google Scholar
• Farrall AL, Smith JR. Eye involvement in primary central nervous system lymphoma. Surv Ophthalmol. 2020;65(5):548–561. doi:10.1016/j.survophthal.2020.02.001.
   Web of Science ®Google Scholar
• Chan CC, Sen HN. Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma. Discov Med. 2013;15:93–100.
   PubMed Web of Science ®Google Scholar
• Cho BJ, Kim DY, Park UC, Lee JY, Yoon YH, Yu HG. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma. Ocul Immunol Inflamm. 2018;26(3):365–371. doi:10.1080/09273948.2017.1421669.
   PubMed Web of Science ®Google Scholar
• Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology. 1999;106(9):1805–1810.doi:10.1016/S0161-6420(99)90341-X.
   PubMed Web of Science ®Google Scholar
• Castellino A, Pulido JS, Johnston PB, et al. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: a single center experience 1990-2018. Am J Hematol. 2019;94(3):291–298.doi:10.1002/ajh.25350.
   PubMed Web of Science ®Google Scholar
• Dalvin LA, Lim LAS, Ancona-Lezama D, et al. Clinical features predictive of survival in patients with vitreoretinal lymphoma: analysis of 70 patients at a single ocular oncology center. Asia-Pac J Ophthalmol. 2020;9(2):110–116.doi:10.1097/APO.0000000000000274.
   PubMed Web of Science ®Google Scholar
• Chan C, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium. Oncologist. 2011;16(11):1589–1599.doi:10.1634/theoncologist.2011-0210.
   PubMed Web of Science ®Google Scholar
• Riemens A, Bromberg J, Touitou V, et al. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study. JAMA Ophthalmol. 2015;133(2):191–197.doi:10.1001/jamaophthalmol.2014.4755.
   PubMed Web of Science ®Google Scholar
• Cimino L, Coassin M, Chan CC, et al. Vitreoretinal lymphomas misdiagnosed as uveitis: lessons learned from a case series. Indian J Ophthalmol. 2016;64(5):369–375.doi:10.4103/0301-4738.185600.
   PubMed Web of Science ®Google Scholar
• Mura M, Buschini E, Iannetta D, De Smet MD. Vitreous biopsy under air. Retina. 2016;36(4):838–839. doi:10.1097/IAE.0000000000000939.
   PubMed Web of Science ®Google Scholar
• Frenkel S, Pe’er J, Kaufman R, Maly B, Habot-Wilner Z. The importance of cytokines analysis in the diagnosis of vitreoretinal lymphoma. Acta Ophthalmol. 2020;98(6):e668–e673. doi:10.1111/aos.14347.
   PubMed Web of Science ®Google Scholar
• Dalal M, Casady M, Moriarty E, et al. Diagnostic procedures in vitreoretinal lymphoma. Ocul Immunol Inflamm. 2014;22(4):270–276.doi:10.3109/09273948.2013.848905.
   PubMed Web of Science ®Google Scholar
• Raja H, Salomão DR, Viswanatha DS, Pulido JS. Prevalence of MYD88 L265P mutation in histologically proven, diffuse large B-cell vitreoretinal lymphoma. Retina. 2016;36(3):624–628. doi:10.1097/IAE.0000000000000996.
   PubMed Web of Science ®Google Scholar
• Smith JR, Rosenbaum JT, Wilson DJ. Role of intravitreal methotrexate in the management of primary central nervous. Ophthalmology. 2002;109(9):1709–1716. doi:10.1016/S0161-6420(02)01125-9.
   PubMed Web of Science ®Google Scholar
• Cicinelli MV, Marchese A, Miserocchi E, et al. Retinal and choroidal changes of vitreoretinal lymphoma from active to remission phase after intravitreal rituximab. Ocul Immunol Inflamm. 2020;28(4):637–646.doi:10.1080/09273948.2019.1616769.
   PubMed Web of Science ®Google Scholar
• Abrey LE, Batchelor TT, Ferreri AJM, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol. 2005;23(22):5034–5043.doi:10.1200/JCO.2005.13.524.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579–586.doi:10.1200/JCO.2006.09.2403.
   PubMed Web of Science ®Google Scholar
• Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular lymphoma. Surv Ophthalmol. 2014;59(5):503–516.doi:10.1016/j.survophthal.2013.12.001.
   PubMed Web of Science ®Google Scholar
• Yonese I, Takase H, Yoshimori M, et al. CD79B mutations in primary vitreoretinal lymphoma: diagnostic and prognostic potential. Eur J Haematol. 2019;102(2):191–196.doi:10.1111/ejh.13191.
   PubMed Web of Science ®Google Scholar
• Favalli EG. Understanding the role of interleukin-6 (IL-6) in the joint and beyond: a comprehensive review of il-6 inhibition for the management of rheumatoid arthritis. Rheumatol Ther. 2020;7(3):473–516. doi:10.1007/s40744-020-00219-2.
   PubMed Web of Science ®Google Scholar
• Bonacini M, Soriano A, Cimino L, et al. Cytokine profiling in aqueous humor samples from patients with non-infectious uveitis associated with systemic inflammatory diseases. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.00358.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Berghmans N, Al-Obeidan SA, et al. The cytokine interleukin-6 and the chemokines CCL20 and CXCL13 are novel biomarkers of specific endogenous uveitic entities. Investig Ophthalmol Vis Sci. 2016;57(11):4606–4613.doi:10.1167/iovs.16-19758.
   PubMed Web of Science ®Google Scholar
• Kuo DE, Wei MM, Knickelbein JE, et al. Logistic regression classification of primary vitreoretinal lymphoma versus uveitis by interleukin 6 and interleukin 10 levels. Ophthalmology:1–7. 2020;127(7):956–962. doi:10.1016/j.ophtha.2020.01.042.
   Web of Science ®Google Scholar
• Kimura K, Usui Y, Goto H, et al. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol. 2012;56(4):383–389.doi:10.1007/s10384-012-0150-7.
   PubMed Web of Science ®Google Scholar
• Načinović-Duletić A, Štifter S, Š D, Ž Š, Jonjić N. Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma. Int J Lab Hematol. 2008;30(3):230–239. doi:10.1111/j.1751-553X.2007.00951.x.
   PubMed Web of Science ®Google Scholar
• Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7(3):211–217. doi:10.1016/j.ccr.2005.02.013.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Ponzetta A, Inforzato A, Jaillon S. Innate immunity, inflammation and tumour progression: double-edged swords. J Intern Med. 2019;285(5):524–532. doi:10.1111/joim.12886.
   PubMed Web of Science ®Google Scholar
• Neurath MF, Finotto S. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev. 2011;22(2):83–89. doi:10.1016/j.cytogfr.2011.02.003.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature07205.
   PubMed Web of Science ®Google Scholar
• Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report. Ann Oncol. 2007;18(11):1851–1855.doi:10.1093/annonc/mdm340.
   PubMed Web of Science ®Google Scholar
• Klimova A, Heissigerova J, Rihova E, et al. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse. Br J Ophthalmol. 2018;102(11):1579–1585.doi:10.1136/bjophthalmol-2017-311574.
   PubMed Web of Science ®Google Scholar
• Hashida N, Nakai K, Saitoh N, Nishida K. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma. Graefe’s Arch Clin Exp Ophthalmol. 2014;252(4):687–693. doi:10.1007/s00417-014-2584-8.
   PubMed Web of Science ®Google Scholar
• Ahmed AH, Foster CS, Shields CL. Association of disease location and treatment with survival in diffuse large B-cell lymphoma of the eye and ocular adnexal region. JAMA Ophthalmol. 2017;135(10):1062–1068. doi:10.1001/jamaophthalmol.2017.3286.
   PubMed Web of Science ®Google Scholar
• Ma WL, Hou HA, Hsu YJ, et al. Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection. Ann Hematol. 2016;95(4):593–601.doi:10.1007/s00277-015-2582-x.
   PubMed Web of Science ®Google Scholar
• Kim MM, Dabaja BS, Medeiros J, et al. Survival outcomes of primary intraocular lymphoma a single-institution experience. Am J Clin Oncol Cancer Clin Trials. 2016;39(2):109–113. doi:10.1097/COC.0000000000000028.
   PubMed Web of Science ®Google Scholar
• Chan CC, Wallace DJ. Intraocular lymphoma: update on diagnosis and management. Cancer Control. 2004;11(5):285–295. doi:10.1177/107327480401100502.
   PubMedGoogle Scholar
• Hormigo A, Abrey L, Heinemann MH, DeAngelis LM. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. Br J Haematol. 2004;126(2):202–208. doi:10.1111/j.1365-2141.2004.05028.x.
   PubMed Web of Science ®Google Scholar
• Vosganian GS, Boisot S, Hartmann KI, et al. Primary intraocular lymphoma: a review. J Neurooncol. 2011;105(2):127–134.doi:10.1007/s11060-011-0618-1.
   PubMed Web of Science ®Google Scholar
• Kim SK, Chan CC, Wallace DJ. Management of primary intraocular lymphoma. Curr Oncol Rep. 2005;7(1):74–79. doi:10.1007/s11912-005-0029-6.
   PubMedGoogle Scholar
• McCann KJ, Ashton-Key M, Smith KA, Stevenson FK, Ottensmeier CH. Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. Blood. 2009;113(19):4677–4680. doi:10.1182/blood-2008-09-179366.
   PubMed Web of Science ®Google Scholar
• Davis JL. Intraocular lymphoma: a clinical perspective. Eye. 2013;27(2):153–162. doi:10.1038/eye.2012.250.
   PubMed Web of Science ®Google Scholar